Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25514 | 279 | 44.7 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
220 | 3 | CYTOMEGALOVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 50388 |
545 | 2 | VIROLOGY//JOURNAL OF VIROLOGY//PSEUDORABIES VIRUS | 14689 |
25514 | 1 | HERPES SIMPLEX VIRUS VECTOR//W ROXBURY VA HOSP//HELPER VIRUS FREE PACKAGING | 279 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HERPES SIMPLEX VIRUS VECTOR | authKW | 1519597 | 7% | 73% | 19 |
2 | W ROXBURY VA HOSP | address | 1474628 | 6% | 84% | 16 |
3 | HELPER VIRUS FREE PACKAGING | authKW | 437782 | 1% | 100% | 4 |
4 | HSV AMPLICON | authKW | 383052 | 3% | 50% | 7 |
5 | HSV 1 AMPLICON VECTORS | authKW | 250157 | 1% | 57% | 4 |
6 | GLUTAMATERGIC NEURON SPECIFIC EXPRESSION | authKW | 246251 | 1% | 75% | 3 |
7 | NEUROFILAMENT PROMOTER | authKW | 246251 | 1% | 75% | 3 |
8 | HERPES SIMPLEX VIRUS TYPE 1 VECTORS | authKW | 218891 | 1% | 100% | 2 |
9 | HSV 1 AMPLICON VIRAL VECTOR | authKW | 218891 | 1% | 100% | 2 |
10 | HSV 1 BASED AMPLICONS | authKW | 218891 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biotechnology & Applied Microbiology | 1432 | 31% | 0% | 86 |
2 | Medicine, Research & Experimental | 1210 | 25% | 0% | 70 |
3 | Neurosciences | 1170 | 38% | 0% | 107 |
4 | Genetics & Heredity | 1021 | 26% | 0% | 72 |
5 | Virology | 945 | 14% | 0% | 40 |
6 | Biochemical Research Methods | 232 | 10% | 0% | 29 |
7 | Biochemistry & Molecular Biology | 107 | 20% | 0% | 56 |
8 | CYTOLOGY & HISTOLOGY | 13 | 0% | 0% | 1 |
9 | Cell Biology | 11 | 5% | 0% | 15 |
10 | Behavioral Sciences | 2 | 1% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | W ROXBURY VA HOSP | 1474628 | 6% | 84% | 16 |
2 | CELLULAR BIOL NEUROSCI PROF EDUARDO DE ROB | 145926 | 1% | 67% | 2 |
3 | GILBERT | 113998 | 2% | 21% | 5 |
4 | MOL NEUROONCOL S | 113998 | 2% | 21% | 5 |
5 | BIOL MOL CELLULEDIFFERENT CELL CYCLE GRPU | 109445 | 0% | 100% | 1 |
6 | BNBCB | 109445 | 0% | 100% | 1 |
7 | BRAIN FUNCT GENOMJOINT NEUROPATHOGEN | 109445 | 0% | 100% | 1 |
8 | CENT PREVENT TREATMENT TUMOR | 109445 | 0% | 100% | 1 |
9 | CMCG | 109445 | 0% | 100% | 1 |
10 | CNR INESE MINIST EDUC | 109445 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY | 15878 | 8% | 1% | 22 |
2 | CURRENT GENE THERAPY | 9772 | 3% | 1% | 7 |
3 | MOLECULAR THERAPY | 7892 | 6% | 0% | 16 |
4 | GENE THERAPY | 7145 | 6% | 0% | 16 |
5 | MOLECULAR BRAIN RESEARCH | 1955 | 3% | 0% | 9 |
6 | JOURNAL OF VIROLOGICAL METHODS | 1258 | 3% | 0% | 9 |
7 | JOURNAL OF GENE MEDICINE | 1239 | 1% | 0% | 4 |
8 | BIOTECHNIQUES | 1144 | 3% | 0% | 8 |
9 | JOURNAL OF NEUROSCIENCE METHODS | 940 | 3% | 0% | 8 |
10 | BRAIN RESEARCH | 903 | 7% | 0% | 20 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CUCHET, D , POTEL, C , THOMAS, J , EPSTEIN, AL , (2007) HSV-1 AMPLICON VECTORS: A PROMISING AND VERSATILE TOOL FOR GENE DELIVERY.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 7. ISSUE 7. P. 975-995 | 70 | 45% | 23 |
2 | EPSTEIN, AL , (2009) HSV-1-DERIVED AMPLICON VECTORS: RECENT TECHNOLOGICAL IMPROVEMENTS AND REMAINING DIFFICULTIES - A REVIEW.MEMORIAS DO INSTITUTO OSWALDO CRUZ. VOL. 104. ISSUE 3. P. 399 -410 | 43 | 52% | 14 |
3 | EPSTEIN, AL , (2005) HSV-1-BASED AMPLICON VECTORS: DESIGN AND APPLICATIONS.GENE THERAPY. VOL. 12. ISSUE . P. S154-S158 | 28 | 70% | 18 |
4 | DE SILVA, S , BOWERS, WJ , (2009) HERPES VIRUS AMPLICON VECTORS.VIRUSES-BASEL. VOL. 1. ISSUE 3. P. 594-629 | 50 | 33% | 9 |
5 | CAO, HY , ZHANG, GR , GELLER, AI , (2011) ANTIBODY-MEDIATED TARGETED GENE TRANSFER OF HELPER VIRUS-FREE HSV-1 VECTORS TO RAT NEOCORTICAL NEURONS THAT CONTAIN EITHER NMDA RECEPTOR 2B OR 2A SUBUNITS.BRAIN RESEARCH. VOL. 1415. ISSUE . P. 127-135 | 27 | 48% | 1 |
6 | OEHMIG, A , FRAEFEL, C , BREAKEFIELD, XO , (2004) UPDATE ON HERPESVIRUS AMPLICON VECTORS.MOLECULAR THERAPY. VOL. 10. ISSUE 4. P. 630-643 | 45 | 32% | 35 |
7 | CUCHER, D , EPSTEIN, AL , (2008) FURTHER IMPROVEMENTS IN THE TECHNOLOGY OF HSV-1-BASED AMPLICON VECTORS - HJ FEDEROFF & WJ BOWERS: WO2007143681.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 18. ISSUE 7. P. 797-804 | 23 | 53% | 0 |
8 | JERUSALINSKY, D , BAEZ, MV , EPSTEIN, AL , (2012) HERPES SIMPLEX VIRUS TYPE 1-BASED AMPLICON VECTORS FOR FUNDAMENTAL RESEARCH IN NEUROSCIENCES AND GENE THERAPY OF NEUROLOGICAL DISEASES.JOURNAL OF PHYSIOLOGY-PARIS. VOL. 106. ISSUE 1-2. P. 2-11 | 33 | 32% | 7 |
9 | KASAI, K , SAEKI, Y , (2006) DNA-BASED METHODS TO PREPARE HELPER VIRUS-FREE HERPES AMPLICON VECTORS AND VERSATILE DESIGN OF AMPLICON VECTOR PLASMIDS.CURRENT GENE THERAPY. VOL. 6. ISSUE 3. P. 303 -314 | 26 | 48% | 3 |
10 | ZHANG, GR , ZHAO, H , CAO, HY , GELLER, AI , (2012) OVEREXPRESSION OF EITHER LYSINE-SPECIFIC DEMETHYLASE-1 OR CLOCK, BUT NOT CO-REST, IMPROVES LONG-TERM EXPRESSION FROM A MODIFIED NEUROFILAMENT PROMOTER, IN A HELPER VIRUS-FREE HSV-1 VECTOR SYSTEM.BRAIN RESEARCH. VOL. 1436. ISSUE . P. 157-167 | 23 | 46% | 1 |
Classes with closest relation at Level 1 |